Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XL119 in Relapsed Sensitive Small Cell Lung Cancer
NCT00084487Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Apr 2004
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of becatecarin in small cell lung cancer (SCLC), sponsored by National Cancer Institute. Started Apr 2004; status: terminated.
02
Drugs
becatecarin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00084487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084487.